Home › Funds › Farallon Capital Management › TEVA
Farallon Capital Management position in TEVA
TEVA PHARMACEUTICAL INDS LTD · Health Care
Latest position (Q2 2026)40.00K sh
Reported value held$1.36M
Portfolio Weight0.01%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 5.00M | $100.94M | New |
| Q4 2025 | 40.00K | $1.25M | Reduce |
| Q1 2026 | 354.00K | $10.66M | Add |
| Q2 2026 | 40.00K | $1.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TEVA
- BlackRock Inc 63.89M sh · $2.16B · Q2 2026
- Norges Bank Investment Management 32.30M sh · $1.09B · Q2 2026
- Fidelity Management & Research (FMR) 30.26M sh · $1.03B · Q2 2026
- Capital World Investors 12.54M sh · $424.72M · Q2 2026
- Geode Capital Management 11.61M sh · $391.01M · Q2 2026
- Northern Trust Corp 7.96M sh · $269.58M · Q2 2026
- Wellington Management Group 7.67M sh · $259.90M · Q2 2026
- Morgan Stanley 6.97M sh · $236.10M · Q2 2026
- Goldman Sachs Group 6.13M sh · $207.66M · Q2 2026
- Janus Henderson Group 4.82M sh · $145.08M · Q1 2026
- Citadel Advisors 4.24M sh · $143.75M · Q2 2026
- Bank of America Corp 4.23M sh · $143.23M · Q2 2026